| Breakdown | TTM | Apr 2024 | Apr 2023 | Apr 2023 | Apr 2021 | Apr 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 118.60M | 117.50M | 109.58M | 83.96M | 74.52M | 61.54M |
| Gross Profit | 41.84M | 40.00M | 33.87M | 23.40M | 20.40M | 17.32M |
| EBITDA | 22.47M | 22.68M | 18.02M | 7.53M | 8.04M | 3.56M |
| Net Income | 14.36M | 14.53M | 11.50M | 4.12M | 4.93M | 1.18M |
Balance Sheet | ||||||
| Total Assets | 130.96M | 134.14M | 128.72M | 79.31M | 80.59M | 74.39M |
| Cash, Cash Equivalents and Short-Term Investments | 35.73M | 23.75M | 35.51M | 15.25M | 19.25M | 23.55M |
| Total Debt | 229.00K | 414.00K | 804.00K | 1.21M | 1.51M | 545.00K |
| Total Liabilities | 66.19M | 72.95M | 77.92M | 38.24M | 42.02M | 43.36M |
| Stockholders Equity | 64.77M | 61.19M | 50.80M | 41.08M | 38.58M | 31.04M |
Cash Flow | ||||||
| Free Cash Flow | 7.70M | -7.00M | 31.70M | -2.37M | -2.86M | 9.00M |
| Operating Cash Flow | 11.52M | -3.25M | 36.60M | -397.00K | -99.00K | 9.79M |
| Investing Cash Flow | -829.00K | -338.00K | -8.98M | -1.73M | -2.53M | -773.00K |
| Financing Cash Flow | -3.85M | -8.03M | -4.38M | -1.94M | -1.72M | -1.54M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £148.03M | 7.50 | 20.23% | 3.00% | 43.98% | 97.22% | |
70 Outperform | £1.02B | 8.29 | 19.28% | 3.66% | -6.21% | 0.75% | |
65 Neutral | £282.55M | 31.31 | 4.06% | 1.52% | 2.12% | 23.22% | |
64 Neutral | £239.05M | 16.52 | 22.79% | 1.55% | 10.56% | 18.07% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
51 Neutral | £21.28M | -7.99 | -7.20% | 0.39% | -5.19% | 11.73% | |
46 Neutral | £55.25M | -2.27 | -24.67% | 12.88% | -12.44% | -346.71% |